Login to Your Account

Nano-sized radiation enhancers for tumor treatment soon entering the European market

By Bernard Banga
Staff Writer

Wednesday, October 12, 2016

PARIS – Nanobiotix SA has submitted its lead product NBTXR3 – the first generation of nanoparticle radio-enhancers targeting human cells – for first market approval in Europe.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription